Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.27
Price to sales ratio
1.05
Dividends per share
Dividend yield %

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4184
NAKA
Nakamoto Inc. - Common Stock
3.97 USD+17.80%-0.50%-14.44%-67.59%69.09 M USD
4186
DCGO
DocGo Inc. - Common Stock
0.65 USD+1.56%+8.33%+12.07%-55.78%64.21 M USD
4632
CCM
Concord Medical Services Holdings Limited American Depositary S
4.37 USD-6.62%-7.61%+2.58%+36.99%18.97 M USD
4814
BMGL
Basel Medical Group Ltd - ordinary shares
8.18 USD+27.61%+36.56%+1335.09%+1036.11%12.81 M USD

Frequently asked questions about Cryo-Cell International, Inc. Common Stock

What is the Cryo-Cell International, Inc. Common Stock stock price today?

The current price of Cryo-Cell International, Inc. Common Stock (CCEL) is 3.43. Over the past 24 hours, the stock has changed by -1.41%. Follow the CCEL chart for real-time price dynamics.

What is the stock ticker of Cryo-Cell International, Inc. Common Stock?

Cryo-Cell International, Inc. Common Stock trades under the ticker CCEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cryo-Cell International, Inc. Common Stock stock going up?

CCEL has changed by -2.56% over the last week, -0.58% over the last month, and +3.94% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Cryo-Cell International, Inc. Common Stock release financial reports?

Yes. You can track Cryo-Cell International, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Cryo-Cell International, Inc. Common Stock net income for the last quarter?

Cryo-Cell International, Inc. Common Stock reported net income of 47.11 K for the last quarter. The previous quarter showed -3.82 M, which means net income changed by +101.23%.

How many employees does Cryo-Cell International, Inc. Common Stock have?

As of the latest available data, Cryo-Cell International, Inc. Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cryo-Cell International, Inc. Common Stock EBITDA?

Cryo-Cell International, Inc. Common Stock EBITDA is 820.79 K, and its EBITDA margin is 10.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cryo-Cell International, Inc. Common Stock stock?

You can buy Cryo-Cell International, Inc. Common Stock (CCEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cryo-Cell International, Inc. Common Stock stock?

Investing in Cryo-Cell International, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CCEL chart and related analysis on metatrader.com as part of your research.

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

News